EP
ANGO icon

Essential Partners’s AngioDynamics ANGO Stock Holding History

Essential Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83K Buy
141
+115
+442% +$1.31K ﹤0.01% 2006
2026
Q1 		$296 Sell
26
-3
-10% -$33 ﹤0.01% 2554
2025
Q4 		$372 Buy
29
+15
+107% +$185 ﹤0.01% 2298
2025
Q3 		$156 Buy
14
+1
+8% +$10 ﹤0.01% 2434
2025
Q2 		$129 Buy
+13
New +$127 ﹤0.01% 2033

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Essential Partners's ANGO Position: Q2 2026 in Review

Essential Partners increased its AngioDynamics (ANGO) stake by 442% in Q2 2026, buying an estimated $1.31K and bringing the position to 141 shares worth $1.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Essential Partners first reported a position in ANGO in Q2 2025 and has held it in 5 quarters since. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Essential Partners held 141 shares of AngioDynamics worth $1.83K as of Q2 2026.
  • Essential Partners bought 115 AngioDynamics shares in Q2 2026, an estimated $1.31K.
  • AngioDynamics made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2006 holding.
  • Essential Partners first reported a position in AngioDynamics in Q2 2025 and has held it in 5 quarters since.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.